Biotrin Parvovirus B19 Igm

Summary Biotrin Parvovirus B19 IgM tests are being recalled across Canada because they are not performing as expected. This is a Class I recall, meaning there is a serious potential health risk. The affected tests were distributed throughout Canada.

Product
Biotrin Parvovirus B19 IgM
Reason
Performance
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DEVICES
Recall date
2025-06-20
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DEVICES

Recall details on Nibble Recalls: https://trynibble.app/recalls/59d13896-3eaf-4752-a698-5b6b6d39bea9